Global Biotechnology Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report aims to provide a comprehensive presentation of the global market for Biotechnology, with and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biotechnology.
The Biotechnology market size considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biotechnology market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biotechnology manufacturers, new entrants, and industry chain related companies in this market with information for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
The global Biotechnology market size in 2022 is 1023920.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 29.00% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Biotechnology market include Abbott (U.S.), Agilent Technologies Inc. (U.S.), Danaher (U.S.), BD (U.S.), and Bio-Rad Laboratories Inc. (U.S.). The share of the top 3 players in the Biotechnology market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Biotechnology market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Nano Biotechnology accounted for XX% of Biotechnology market in 2022. PCR Technology share of XX%.
Pharmaceutical and Biotechnology Companies accounted for XX% of the Biotechnology market in 2022. Contract Research Organizations accounts for XX%.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Highlights-Regions
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
South America
Brazil
Argentina
Colombia
MEA
Saudi Arabia
Egypt
Nigeria
Player list
Abbott (U.S.)
Agilent Technologies Inc. (U.S.)
Danaher (U.S.)
BD (U.S.)
Bio-Rad Laboratories Inc. (U.S.)
General Electric (U.S.)
bioMérieux SA (Frnace)
LONZA (Switzerland)
F. Hoffmann-La Roche Ltd. (Switzerland)
Hoefer, Inc. (U.S.)
PerkinElmer Inc. (U.S.)
Merck KGaA (Germany)
Promega Corporation (U.S.)
Quality Biological (U.S.)
Siemens (Germany)
Bio-Techne (U.S.)
TAKARA HOLDINGS INC. (Japan)
Sysmex Corporation (Japan)
Tosoh Corporation (Japan)
Ortho Clinical Diagnostics (U.S.)
Olympus Corporation (Japan)
Types list
Nano Biotechnology
PCR Technology
DNA Sequencing
Chromatography
Tissue Engineering and Regeneration
Cell Based Assays
Fermentation
Others
Application list
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic and Research Institutes
Others
Table of Content
1 Biotechnology Market Overview
1.1 Biotechnology Product Overview
1.1.1 Biotechnology Product Scope
1.1.2 Biotechnology Market Status and Outlook
1.2 Global Biotechnology Market Size Overview by Region 2018 VS 2022VS 2029
1.3 Global Biotechnology Market Size by Region (2018-2029)
1.4 Global Biotechnology Historic Market Size by Region (2018-2023)
1.5 Global Biotechnology Market Size Forecast by Region (2023-2029)
1.6 Key Regions, Biotechnology Market Size (2018-2029)
1.6.1 North America Biotechnology Market Size (2018-2029)
1.6.2 Europe Biotechnology Market Size (2018-2029)
1.6.3 Asia-Pacific Biotechnology Market Size (2018-2029)
1.6.4 Latin America Biotechnology Market Size (2018-2029)
1.6.5 Middle East & Africa Biotechnology Market Size (2018-2029)
2 Biotechnology Market Overview by Type
2.3 Global Biotechnology Market Size by Type: 2018 VS 2022 VS 2029
2.4 Global Biotechnology Historic Market Size by Type (2018-2023)
2.5 Global Biotechnology Forecasted Market Size by Type (2023-2029)
2.6 Key Regions Market Size Segment by Type (2018-2029)
2.6.1 North America Biotechnology Market Size Breakdown by Type (2018-2029)
2.6.2 Europe Biotechnology Market Size Breakdown by Type
2.6.3 Asia-Pacific Biotechnology Market Size Breakdown by Type
2.6.4 Latin America Biotechnology Market Size Breakdown by Type
2.6.5 Middle East and Africa Biotechnology Market Size Breakdown by Type
3 Biotechnology Market Overview by Application
3.3 Global Biotechnology Market Size by Application: 2018 VS 2022 VS 2029
3.4 Global Biotechnology Historic Market Size by Application (2018-2023)
3.5 Global Biotechnology Forecasted Market Size by Application (2023-2029)
3.6 Key Regions Market Size Segment by Application (2018-2029)
3.6.1 North America Biotechnology Market Size Breakdown by Application (2018-2029)
3.6.2 Europe Biotechnology Market Size Breakdown by Application
3.6.3 Asia-Pacific Biotechnology Market Size Breakdown by Application
3.6.4 Latin America Biotechnology Market Size Breakdown by Application
3.6.5 Middle East and Africa Biotechnology Market Size Breakdown by Application
4 Biotechnology Competition Analysis by Players
4.1 Global Biotechnology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biotechnology as of 2022)
4.3 Date of Key Players Enter into Biotechnology Market
4.4 Global Top Players Biotechnology Headquarters and Area Served
4.5 Key Players Biotechnology Product Solution and Service
4.6 Competitive Status
4.6.1 Biotechnology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 North America Biotechnology Market Segment by Country
5.1 North America Biotechnology Market Size by Country (2018-2029)
5.2 United States
5.3 Canada
6 Europe Biotechnology Market Segment by Country
6.1 Europe Biotechnology Market Size by Country (2018-2029)
6.2 Germany
6.3 France
6.4 U.K.
6.5 Italy
6.6 Russia
6.7 Nordic
6.8 Rest of Europe
7 Asia-Pacific Biotechnology Market Segment by Country
7.1 Asia-Pacific Biotechnology Market Size by Region (2018-2029)
7.2 China
7.3 Japan
7.4 South Korea
7.5 Southeast Asia
7.6 India
7.7 Australia
7.8 Rest of Asia-Pacific
8 Latin America Biotechnology Market Segment by Country
8.1 Latin America Biotechnology Market Size by Country (2018-2029)
8.2 Mexico
8.3 Brazil
8.4 Rest of Latin America
9 Middle East and Africa Biotechnology Market Segment by Country
9.1 Middle East & Africa Biotechnology Market Size by Country (2018-2029)
9.2 Turkey
9.3 Saudi Arabia
9.4 UAE
9.5 Rest of Middle East & Africa
10 Manufacturers Profiles
10.1 Abbott (U.S.)
10.1.1 Abbott (U.S.) Information
10.1.2 Business Overview
10.1.3 Abbott (U.S.) Biotechnology Revenue, Gross Margin
10.1.4 Biotechnology Products Offered
10.1.5 Abbott (U.S.) Recent Development
10.2 Agilent Technologies Inc. (U.S.)
10.2.1 Agilent Technologies Inc. (U.S.) Information
10.2.2 Business Overview
10.2.3 Agilent Technologies Inc. (U.S.) Biotechnology Revenue, Gross Margin
10.2.4 Biotechnology Products Offered
10.2.5 Agilent Technologies Inc. (U.S.) Recent Development
10.3 Danaher (U.S.)
10.3.1 Danaher (U.S.) Information
10.3.2 Business Overview
10.3.3 Danaher (U.S.) Biotechnology Revenue, Gross Margin
10.3.4 Biotechnology Products Offered
10.3.5 Danaher (U.S.) Recent Development
10.4 BD (U.S.)
10.4.1 BD (U.S.) Information
10.4.2 Business Overview
10.4.3 BD (U.S.) Biotechnology Revenue, Gross Margin
10.4.4 Biotechnology Products Offered
10.4.5 BD (U.S.) Recent Development
10.5 Bio-Rad Laboratories Inc. (U.S.)
10.5.1 Bio-Rad Laboratories Inc. (U.S.) Information
10.5.2 Business Overview
10.5.3 Bio-Rad Laboratories Inc. (U.S.) Biotechnology Revenue, Gross Margin
10.5.4 Biotechnology Products Offered
10.5.5 Bio-Rad Laboratories Inc. (U.S.) Recent Development
10.6 General Electric (U.S.)
10.6.1 General Electric (U.S.) Information
10.6.2 Business Overview
10.6.3 General Electric (U.S.) Biotechnology Revenue, Gross Margin
10.6.4 Biotechnology Products Offered
10.6.5 General Electric (U.S.) Recent Development
10.7 bioMérieux SA (Frnace)
10.7.1 bioMérieux SA (Frnace) Information
10.7.2 Business Overview
10.7.3 bioMérieux SA (Frnace) Biotechnology Revenue, Gross Margin
10.7.4 Biotechnology Products Offered
10.7.5 bioMérieux SA (Frnace) Recent Development
10.8 LONZA (Switzerland)
10.8.1 LONZA (Switzerland) Information
10.8.2 Business Overview
10.8.3 LONZA (Switzerland) Biotechnology Revenue, Gross Margin
10.8.4 Biotechnology Products Offered
10.8.5 LONZA (Switzerland) Recent Development
10.9 F. Hoffmann-La Roche Ltd. (Switzerland)
10.9.1 F. Hoffmann-La Roche Ltd. (Switzerland) Information
10.9.2 Business Overview
10.9.3 F. Hoffmann-La Roche Ltd. (Switzerland) Biotechnology Revenue, Gross Margin
10.9.4 Biotechnology Products Offered
10.9.5 F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development
10.10 Hoefer, Inc. (U.S.)
10.10.1 Hoefer, Inc. (U.S.) Information
10.10.2 Business Overview
10.10.3 Hoefer, Inc. (U.S.) Biotechnology Revenue, Gross Margin
10.10.4 Biotechnology Products Offered
10.10.5 Hoefer, Inc. (U.S.) Recent Development
10.11 PerkinElmer Inc. (U.S.)
10.11.1 PerkinElmer Inc. (U.S.) Information
10.11.2 Business Overview
10.11.3 PerkinElmer Inc. (U.S.) Biotechnology Revenue, Gross Margin
10.11.4 Biotechnology Products Offered
10.11.5 PerkinElmer Inc. (U.S.) Recent Development
10.12 Merck KGaA (Germany)
10.12.1 Merck KGaA (Germany) Information
10.12.2 Business Overview
10.12.3 Merck KGaA (Germany) Biotechnology Revenue, Gross Margin
10.12.4 Biotechnology Products Offered
10.12.5 Merck KGaA (Germany) Recent Development
10.13 Promega Corporation (U.S.)
10.13.1 Promega Corporation (U.S.) Information
10.13.2 Business Overview
10.13.3 Promega Corporation (U.S.) Biotechnology Revenue, Gross Margin
10.13.4 Biotechnology Products Offered
10.13.5 Promega Corporation (U.S.) Recent Development
10.14 Quality Biological (U.S.)
10.14.1 Quality Biological (U.S.) Information
10.14.2 Business Overview
10.14.3 Quality Biological (U.S.) Biotechnology Revenue, Gross Margin
10.14.4 Biotechnology Products Offered
10.14.5 Quality Biological (U.S.) Recent Development
10.15 Siemens (Germany)
10.15.1 Siemens (Germany) Information
10.15.2 Business Overview
10.15.3 Siemens (Germany) Biotechnology Revenue, Gross Margin
10.15.4 Biotechnology Products Offered
10.15.5 Siemens (Germany) Recent Development
10.16 Bio-Techne (U.S.)
10.16.1 Bio-Techne (U.S.) Information
10.16.2 Business Overview
10.16.3 Bio-Techne (U.S.) Biotechnology Revenue, Gross Margin
10.16.4 Biotechnology Products Offered
10.16.5 Bio-Techne (U.S.) Recent Development
10.17 TAKARA HOLDINGS INC. (Japan)
10.17.1 TAKARA HOLDINGS INC. (Japan) Information
10.17.2 Business Overview
10.17.3 TAKARA HOLDINGS INC. (Japan) Biotechnology Revenue, Gross Margin
10.17.4 Biotechnology Products Offered
10.17.5 TAKARA HOLDINGS INC. (Japan) Recent Development
10.18 Sysmex Corporation (Japan)
10.18.1 Sysmex Corporation (Japan) Information
10.18.2 Business Overview
10.18.3 Sysmex Corporation (Japan) Biotechnology Revenue, Gross Margin
10.18.4 Biotechnology Products Offered
10.18.5 Sysmex Corporation (Japan) Recent Development
10.19 Tosoh Corporation (Japan)
10.19.1 Tosoh Corporation (Japan) Information
10.19.2 Business Overview
10.19.3 Tosoh Corporation (Japan) Biotechnology Revenue, Gross Margin
10.19.4 Biotechnology Products Offered
10.19.5 Tosoh Corporation (Japan) Recent Development
10.20 Ortho Clinical Diagnostics (U.S.)
10.20.1 Ortho Clinical Diagnostics (U.S.) Information
10.20.2 Business Overview
10.20.3 Ortho Clinical Diagnostics (U.S.) Biotechnology Revenue, Gross Margin
10.20.4 Biotechnology Products Offered
10.20.5 Ortho Clinical Diagnostics (U.S.) Recent Development
10.21 Olympus Corporation (Japan)
10.21.1 Olympus Corporation (Japan) Information
10.21.2 Business Overview
10.21.3 Olympus Corporation (Japan) Biotechnology Revenue, Gross Margin
10.21.4 Biotechnology Products Offered
10.21.5 Olympus Corporation (Japan) Recent Development
11 Biotechnology Market Dynamics
11.1 Biotechnology Industry Trends
11.2 Biotechnology Growth Drivers
11.3 Biotechnology Market Challenges
11.4 Biotechnology Market Restraints
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 A Methodology
13.1.1 Research Process
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 B Data Source
13.2.1 Legal Disclaimer
Tables & Figures:
List of Tables and Figures
Table Global Biotechnology Market Size Overview by Region 2018 VS 2022VS 2029
Table Global Biotechnology Market Size by Region (2018-2029)
Table Global Biotechnology Market Size by Region (2018-2023)
Table Global Biotechnology Market Size by Region (2023-2029)
Figure North America Biotechnology Market Size (US$ Million) Growth Rate (2018-2029)
Figure Europe Biotechnology Market Size (US$ Million) Growth Rate (2018-2029)
Figure Asia-Pacific Biotechnology Market Size (US$ Million) Growth Rate (2018-2029)
Figure Latin America Biotechnology Market Size (US$ Million) Growth Rate (2018-2029)
Figure Middle East & Africa Biotechnology Market Size (US$ Million) Growth Rate (2018-2029)
Table Global Biotechnology Market Size by Type: 2018 VS 2022 VS 2029
Table Global Biotechnology Historic Market Size by Type (2018-2023)
Table Global Biotechnology Forecasted Market Size by Type (2023-2029)
Table North America Biotechnology Market Size Breakdown in Value, by Type
Table Europe Biotechnology Market Size Breakdown in Value, by Type
Table Asia-Pacific Biotechnology Market Size Breakdown in Value, by Type
Table Latin America Biotechnology Market Size Breakdown in Value, by Type
Table Middle East and Africa Biotechnology Market Size Breakdown in Value, by Type
Table Global Biotechnology Market Size by Application: 2018 VS 2022 VS 2029
Table Global Biotechnology Historic Market Size by Application (2018-2023)
Table Global Biotechnology Forecasted Market Size by Application (2023-2029)
Table North America Biotechnology Market Size Breakdown in Value, by Application
Table Europe Biotechnology Market Size Breakdown in Value, by Application
Table Asia-Pacific Biotechnology Market Size Breakdown in Value, by Application
Table Latin America Biotechnology Market Size Breakdown in Value, by Application
Table Middle East and Africa Biotechnology Market Size Breakdown in Value, by Application
Table Global Biotechnology Market Size by Players (2018-2023)
Table Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biotechnology as of 2022)
Table Date of Key Players Enter into Biotechnology Market
Table Global Top Players Biotechnology Headquarters and Area Served
Table Key Players Biotechnology Product Solution and Service
Table Biotechnology Market Concentration Rate
Table Mergers & Acquisitions, Expansion Plans
Table North America Biotechnology Market Size by Country (2018-2029)
Figure United States Biotechnology Market Size and Growth Rate 2018-2029
Figure Canada Biotechnology Market Size and Growth Rate 2018-2029
Table Europe Biotechnology Market Size by Country (2018-2029)
Figure Germany Biotechnology Market Size and Growth Rate 2018-2029
Figure France Biotechnology Market Size and Growth Rate 2018-2029
Figure U.K.Biotechnology Market Size and Growth Rate 2018-2029
Figure Italy Biotechnology Market Size and Growth Rate 2018-2029
Figure Russia Biotechnology Market Size and Growth Rate 2018-2029
Figure Nordic Biotechnology Market Size and Growth Rate 2018-2029
Figure Rest of Europe Biotechnology Market Size and Growth Rate 2018-2029
Table Asia-Pacific Biotechnology Market Size by Country (2018-2029)
Figure China Biotechnology Market Size and Growth Rate 2018-2029
Figure Japan Biotechnology Market Size and Growth Rate 2018-2029
Figure South Korea Biotechnology Market Size and Growth Rate 2018-2029
Figure Southeast Asia Biotechnology Market Size and Growth Rate 2018-2029
Figure India Biotechnology Market Size and Growth Rate 2018-2029
Figure Australia Biotechnology Market Size and Growth Rate 2018-2029
Figure Rest of Asia-Pacific Biotechnology Market Size and Growth Rate 2018-2029
Table Latin America Biotechnology Market Size by Country (2018-2029)
Figure Mexico Biotechnology Market Size and Growth Rate 2018-2029
Figure Brazil Biotechnology Market Size and Growth Rate 2018-2029
Figure Rest of Latin America Biotechnology Market Size and Growth Rate 2018-2029
Table Middle East & Africa Biotechnology Market Size by Country (2018-2029)
Figure Turkey Biotechnology Market Size and Growth Rate 2018-2029
Figure Saudi Arabia Biotechnology Market Size and Growth Rate 2018-2029
Figure UAE Biotechnology Market Size and Growth Rate 2018-2029
Figure Rest of Middle East & Africa Biotechnology Market Size and Growth Rate 2018-2029
Table Abbott (U.S.) Basic Information
Table Abbott (U.S.) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Abbott (U.S.) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Abbott (U.S.) Recent Development
Table Agilent Technologies Inc. (U.S.) Basic Information
Table Agilent Technologies Inc. (U.S.) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Agilent Technologies Inc. (U.S.) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Agilent Technologies Inc. (U.S.) Recent Development
Table Danaher (U.S.) Basic Information
Table Danaher (U.S.) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Danaher (U.S.) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Danaher (U.S.) Recent Development
Table BD (U.S.) Basic Information
Table BD (U.S.) Biotechnology Revenue, Gross Margin (2018-2023)
Figure BD (U.S.) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table BD (U.S.) Recent Development
Table Bio-Rad Laboratories Inc. (U.S.) Basic Information
Table Bio-Rad Laboratories Inc. (U.S.) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Bio-Rad Laboratories Inc. (U.S.) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Bio-Rad Laboratories Inc. (U.S.) Recent Development
Table General Electric (U.S.) Basic Information
Table General Electric (U.S.) Biotechnology Revenue, Gross Margin (2018-2023)
Figure General Electric (U.S.) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table General Electric (U.S.) Recent Development
Table bioMérieux SA (Frnace) Basic Information
Table bioMérieux SA (Frnace) Biotechnology Revenue, Gross Margin (2018-2023)
Figure bioMérieux SA (Frnace) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table bioMérieux SA (Frnace) Recent Development
Table LONZA (Switzerland) Basic Information
Table LONZA (Switzerland) Biotechnology Revenue, Gross Margin (2018-2023)
Figure LONZA (Switzerland) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table LONZA (Switzerland) Recent Development
Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information
Table F. Hoffmann-La Roche Ltd. (Switzerland) Biotechnology Revenue, Gross Margin (2018-2023)
Figure F. Hoffmann-La Roche Ltd. (Switzerland) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development
Table Hoefer, Inc. (U.S.) Basic Information
Table Hoefer, Inc. (U.S.) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Hoefer, Inc. (U.S.) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Hoefer, Inc. (U.S.) Recent Development
Table PerkinElmer Inc. (U.S.) Basic Information
Table PerkinElmer Inc. (U.S.) Biotechnology Revenue, Gross Margin (2018-2023)
Figure PerkinElmer Inc. (U.S.) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table PerkinElmer Inc. (U.S.) Recent Development
Table Merck KGaA (Germany) Basic Information
Table Merck KGaA (Germany) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Merck KGaA (Germany) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Merck KGaA (Germany) Recent Development
Table Promega Corporation (U.S.) Basic Information
Table Promega Corporation (U.S.) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Promega Corporation (U.S.) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Promega Corporation (U.S.) Recent Development
Table Quality Biological (U.S.) Basic Information
Table Quality Biological (U.S.) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Quality Biological (U.S.) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Quality Biological (U.S.) Recent Development
Table Siemens (Germany) Basic Information
Table Siemens (Germany) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Siemens (Germany) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Siemens (Germany) Recent Development
Table Bio-Techne (U.S.) Basic Information
Table Bio-Techne (U.S.) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Bio-Techne (U.S.) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Bio-Techne (U.S.) Recent Development
Table TAKARA HOLDINGS INC. (Japan) Basic Information
Table TAKARA HOLDINGS INC. (Japan) Biotechnology Revenue, Gross Margin (2018-2023)
Figure TAKARA HOLDINGS INC. (Japan) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table TAKARA HOLDINGS INC. (Japan) Recent Development
Table Sysmex Corporation (Japan) Basic Information
Table Sysmex Corporation (Japan) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Sysmex Corporation (Japan) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Sysmex Corporation (Japan) Recent Development
Table Tosoh Corporation (Japan) Basic Information
Table Tosoh Corporation (Japan) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Tosoh Corporation (Japan) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Tosoh Corporation (Japan) Recent Development
Table Ortho Clinical Diagnostics (U.S.) Basic Information
Table Ortho Clinical Diagnostics (U.S.) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Ortho Clinical Diagnostics (U.S.) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Ortho Clinical Diagnostics (U.S.) Recent Development
Table Olympus Corporation (Japan) Basic Information
Table Olympus Corporation (Japan) Biotechnology Revenue, Gross Margin (2018-2023)
Figure Olympus Corporation (Japan) Revenue Market Share 2018-2023
Table Biotechnology Products Offered
Table Olympus Corporation (Japan) Recent Development
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report
Research Methodology:
Global Biotechnology Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|